Terns Pharmaceuticals CEO Senthil Sundaram has resigned from his position for health reasons.
Senthil Sundaram Terns disclosed in an SEC filing in January of last year that Sundaram had received a cancer diagnosis and would “undergo aggressive treatment, including chemotherapy.” At…
Click here to view original post
